Solarea Peer Review Publication Reveals Green Olives and Other Fruits and Vegetables Have Vast Microbial Diversity with Potential to Provide Probiotic Functionality

“The discoveries of the Solarea platform have so many important applications for our health,” said Rachel Raymond, commercial director of Solarea. “Beyond menopause, we are developing products in other markets that also have the potential to improve the quality of life for many people. We see the potential for this technology to be applied in pharmaceutical development, animal health and agriculture. Other players in the space are also recognizing the opportunity,” she continued, referring to the recent announcement of Solarea’s partnership with global nutrition leader ADM.

Dr Toledo has dedicated his career to studying microbial diversity in many environments for biotechnology product development and said: “We see a great diversity of species in this set of samples, and the level of diversity intraspecific or ecotypes mirrors what has been seen in the oceans with single-celled cyanobacteria,” and continued, “It’s amazing that we know so much about microbial diversity in extreme habitats, but we don’t know much on the microorganisms that colonize our food and their impact on health”.

ABOUT SOLAREA:
Solarea Bio is a biotechnology company based in Cambridge, Mass. developing new microbiome-based solutions to some of the world’s biggest health problems. Solarea was founded in 2017 by a group of scientists and entrepreneurs with a desire to radically change our understanding of the human microbiome and use its power to improve human health. Solarea’s breakthrough is the result of the combined efforts of the company’s co-founders who linked the discovery of an untapped source of microorganisms with probiotic potential in healthy foods to their applications in inflammatory processes, including including the gut-musculoskeletal axis.

Media contacts:
Rachel Raymond
Solarea Bio
[email protected]


SOURCE Solarea Bio

Jacob L. Thornton